Medical device related pressure injuries in COVID-19 patients followed up in an intensive care unit

Abstract

Aim:The aim of this study is to determine the prevalence of medical device-related pressure injuries in COVID-19 patients. Material and Method:This study was conducted with a cross-sectional and retrospective design. The data of 436 patients who were followed up and treated in the Anesthesia and Reanimation Intensive Care Unit with the diagnosis of COVID-19 disease between 11.03.2020-31.02.2021 in a Training and Research Hospital in İstanbul were included in the study. The sample of the study consisted of 32 patients out of 436 patients who met the sampling criteria. The data obtained by retrospective reviewing of the patient records were analyzed through the "Patient Information Form" and "Pressure Injury Stage" forms.Results: Medical device-related pressure injury developed in 32 (7.3%) of 436 patients examined in the study on the specified dates. 90.6% of these patients were male, and the average age was 67.5. 43.7% had comorbid diseases. According to the Braden Risk Assessment Scale, 25% of these patients had medium and 71.8% high risk. Medical devices that cause pressure injury were continuous positive airway pressure mask (n=13), intubation tube (n=7), nasogastric tube (n=5), nasal cannula (n=3), gel pads (n=3), and oxygen mask (n=1). Conclusion:In this study, the potential factors in the study that may have led to the incidence of medical device-related pressure injury specific to COVID-19 disease include the rapid increase in the need for respiratory support, ischemia caused by this infection, and the use of prone position.

Analysis of the factors that affect survival among patients who developed subcutaneous emphysema monitored on COVID-19 diagnosis: single-centred research

“…In a study carried out by Jones et al (13), barotrauma was found to be a frequent complication in severe COVID-19 patients, and it was predicated that ventilation support to these patients should be adjusted in optimal level. It can be claimed that the patients included in the present study developed pneumothorax, pneumomediastinum and subcutaneous emphysema secondary to barotrauma (9,11).…”

“…Pulmonary parenchymal damage among COVID-19 patients brings about complications related to barotrauma (9)(10)(11). In a study carried out by Jones et al (13), barotrauma was found to be a frequent complication in severe COVID-19 patients, and it was predicated that ventilation support to these patients should be adjusted in optimal level.…”

“…The COVID-19 patients with pulmonary involvement frequently develop pneumothorax, pneumomediastinum and subcutaneous emphysema (8). The severe COVID-19 patients monitorized by invasive and non-invasive mechanical ventilation and positive pressure devices (9). Especially in patients with parenchymal involvement, there may appear life-threatening complications such as barotrauma-related pneumothorax, haemothorax, pneumomediastinum and subcutaneous emphysema (8)(9)(10).…”

“…The severe COVID-19 patients monitorized by invasive and non-invasive mechanical ventilation and positive pressure devices (9). Especially in patients with parenchymal involvement, there may appear life-threatening complications such as barotrauma-related pneumothorax, haemothorax, pneumomediastinum and subcutaneous emphysema (8)(9)(10). Subcutaneous emphysema is defined as abnormal level of air and gas in subcutaneous tissues.…”

Research trends and global productivity on mechanical ventilation with the impact of COVID-19: a bibliometric analysis in the period 1980-2021

“…With the COVID-19 pandemic, the importance of MV has emerged once again due to respiratory support, which is one of the most important parts of the treatment for respiratory failure in patients with COVID-19 pneumonia (14,36,37). This situation was seen with the increase of publications on MV during the pandemic period.…”